2023-11-02 10:18:36
Bristol Myers Squibb announces that its Board of Directors has unanimously elected Christopher Boerner as Chairman of the Board, effective April 1, 2024. He succeeds Giovanni Caforio, who will retire following 23 years of service . Christopher Boerner has been named executive vice president, chief operating officer: Effective November 1, Christopher Boerner will be chief executive officer of Bristol Myers Squibb. Joining BMS in 2015, Christopher Boerner was named executive vice president and chief marketing officer in August 2018.
He previously held leadership positions at Seattle Genetics and Genentech (Roche Group), following working for McKinsey & Company, serving global pharmaceutical clients.
1698921221
#Bristol #Myers #Squibb #future #CEO #Christopher #Boerner #elected #chairman #board #November #a.m
